Eledon Pharmaceuticals, Inc. — Director's Dealing 2021

Jul 10, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Eledon Pharmaceuticals, Inc. (ELDN)
CIK: 0001404281
Period of Report: 2021-07-01

Reporting Person: Hillson Jan (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$7.68	2031-07-01	Common Stock (40000)		Direct

Footnotes

F1: This option represents a right to purchase up to 40,000 shares of Common Stock, which option vests with respect to 20,000 shares on July 1, 2022 and with respect to 20,000 shares on July 1, 2023.